    | With in-depth industry experience and expertise, GE Capital, Healthcare Financial Services’ dedicated Life Science Finance team has worked with more than 500 companies and provided over $2.5 billion in financing to the market. Click here to find out more and take our online poll. | - Ovarian cancer patients with BRCA2 mutation more likely to survive
 A study in the Journal of the American Medical Association found that ovarian cancer patients carrying the BRCA2 gene variation, which is linked to an increased risk of breast and ovarian cancers, have higher survival rates than women with the BRCA1 mutation and those without either gene variation. Researchers found that patients with the BRCA2 mutation are more likely to respond to chemotherapy. The findings suggest that BRCA2 and BRCA1 are different mutations that should be studied separately, the study author said. HealthDay News (10/11)       - Caltech researchers modernize the Petri dish
Engineers and biologists at the California Institute of Technology have developed a microscope-free culture dish they call the ePetri. The culture is placed on an image-sensor chip, with a smartphone's LED screen mounted over the chip. The apparatus is placed in an incubator and wired to a computer outside the incubator. Observers can see the entire culture and zoom in on cells of interest. The researchers describe their invention in the Proceedings of the National Academy of Sciences. CNET (10/10)  | Are you harnessing the power of standardization to boost your bottom line? Standards and conformance are powerful tools for reducing costs and expanding markets. C-suite executives at major U.S. companies are supporting standardization to save millions and gain a competitive advantage. Shouldn’t you? Visit www.standardsboostbusiness.org. |
 - Pharma execs seek innovative drug-development partnerships
Pharmaceutical companies are looking for partnership opportunities to accelerate drug development, according to a roundtable of industry executives led by the Tufts Center for the Study of Drug Development. "Drug developers have gotten the message that they need to innovate better, faster and cheaper -- without sacrificing patient safety -- and partnering is proving to be an effective strategy," said Kenneth Kaitin, the center's director. PharmaTimes (U.K.) (10/11) - NHGRI offers $31.5M to beef up human genome catalog
The National Human Genome Research Institute is offering up to $31.5 million for three projects to deepen the understanding of the human genome. In one project, $23 million will be awarded next year to expand the genetic maps for cells, tissues and genomic activities. Another project will spend $3 million to develop improved methods of data analysis for the study of disease. The NHGRI will also spend $5.5 million for a data analysis center and a data management center. GenomeWeb Daily News (10/10) 
- Group raises concern over slow pace of biotech crop approvals in EU
EuropaBio said in a report that the slow pace of gaining approval for biotech crops in the European Union could increase the risk of import disruptions. The biotech trade group said it expected the number of biotech crops awaiting approval to reach more than 90 by 2015 and urged the European Commission to reduce the backlog of pending applications by setting goals. "The Commission pays particular attention to authorizations which can have a major impact on trade, and looks for efficiency gains whenever they are possible," said Frederic Vincent, the EU health and consumer spokesman. Reuters (10/11)  | LET’S GO DESIGN: Episode #5
In this episode of SolidWorks’ interactive web series, Jeremy moves closer to the final design of our Hot Rod Baby Buggy and also hot-wires the golf cart motor to show how the aluminum tracks perform flawlessly. Watch at LetsGoDesign.tv. |
 | News from BIO |  |  | | - Ship with FedEx
FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program.
| SmartQuote | | | |  | Whatever you can do, or dream you can, begin it. Boldness has genius, power and magic in it."
--Johann Wolfgang von Goethe,
German writer and scientist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Tuesday, October 11, 2011
- Monday, October 10, 2011
- Friday, October 07, 2011
- Thursday, October 06, 2011
- Wednesday, October 05, 2011
| | | Lead Editor: Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment